Use of the RETeval™ handheld device to assess the risk of diabetic retinopathy – A literature review
References
- Wong TY, Cheung CM, Larsen M, Sharma S, Simó R. Diabetic retinopathy. Nat Rev Dis Primers. 2016; 2: 16012.
- Pereira DM, Shah A, D’Souza M, Simon P, George T, D’Souza N, Suresh S, Baliga MS. Quality of life in people with diabetic retinopathy: Indian study. J Clin Diagn Res. 2017; 11(4): NC01–NC06.
- Pinilla I, Idoipe M, Perdices L, Sanchez-Cano A, Acha J, Lopez-Galvez MI, Cuenca N, Abecia E. Changes in total and inner retinal thicknesses in type 1 diabetes with no retinopathy after 8 years of follow-up. Retina. 2020; 40(7): 1379–1386.
- Fukuo M, Kondo M, Hirose A, Fukushima H, Ikesugi K, Sugimoto M, Kato K, Uchigata Y, Kitano S. Screening for diabetic retinopathy using new mydriasis-free, full-field flicker ERG recording device. Sci Rep. 2016; 6: 36591.
- Maa AY, Feuer WJ, Davis CQ, Pillow EK, Brown TD, Caywood RM, Chasan JE, Fransen SR. A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy. J Diabetes Its Complications. 2016; 30(3): 524–532.
- Deng X, Li Z, Zeng P, Wang J, Liang J, Lan Y. A diagnostic model for screening diabetic retinopathy using the hand-held electroretinogram device RETeval. Front Endocrinol. 2021; 12: 632457.
- Arias-Alvarez M, Tomas-Grasa C, Sopeña-Pinilla M, Orduna-Hospital E, Fernandez-Espinosa G, Bielsa-Alonso S, Acha-Perez J, Rodriguez-Mena D, Pinilla I. Electrophysiological findings in long-term type 1 diabetes patients without diabetic retinopathy using different ERG recording systems. Sci Rep. 2024; 14(1): 3520.
- Zeng Y, Cao D, Yu H, Yang D, Zhuang X, Hu Y, Li J, Yang J, Wu Q, Liu B, et al. Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy. Br J Ophthalmol. 2019; 103(12): 1747–1752.
- Smith SA, Smith SE. Reduced pupillary light reflexes in diabetic autonomic neuropathy. Diabetologia. 1983; 24(5): 330–332.
- Tyrberg M, Lindblad U, Melander A, Lövestam-Adrian M, Ponjavic V, Andréasson S. Electrophysiological studies in newly onset type 2 diabetes without visible vascular retinopathy. Doc Ophthalmol. 2011; 123(3): 193–198.
- Pardue MT, Barnes CS, Kim MK, Aung MH, Amarnath R, Olson DE, Thule PM. Rodent hyperglycemia-induced inner retinal deficits are mirrored in human diabetes. Transl Vis Sci & Technol. 2014; 3(3): 6.
- McCulloch DL, Marmor MF, Brigell MG, Hamilton R, Holder GE, Tzekov R, Bach M. ISCEV Standard for full-field clinical electroretinography (2015 update). Doc Ophthalmol. 2015; 130(1): 1–12.
- Ichio A, Sugimoto M, Matsubara H, Mochida D, Kato K, Kondo M. Effects of intravitreal aflibercept on retinal function and improvement of macular edema associated with diabetic retinopathy. Transl Vis Sci Technol. 2020; 9(11): 2.
- Zeng Y, Cao D, Yang D, Zhuang X, Yu H, Hu Y, Zhang Y, Yang C, He M, Zhang L. Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device. Doc Ophthalmol. 2020; 140(3): 211–220.
- Wali N, Leguire LE. Fundus pigmentation and the dark-adapted electroretinogram. Doc Ophthalmol. 1992; 80(1): 1–11.
- Al Abdlseaed A, McTaggart Y, Ramage T, Hamilton R, McCulloch DL. Light- and dark-adapted electroretinograms (ERGs) and ocular pigmentation: Comparison of brown- and blue-eyed cohorts. Doc Ophthalmol. 2010; 121(2): 135–146.
- Cankurtaran V, Ilhan C, Tekin K, Citirik M, Dirican E, Gurkan E. Use of automated quantitative pupillometric evaluation for monitoring the severity of diabetic retinopathy. Arq Bras Oftalmologia. 2021; 84(1): 37–44.
- Smith SA, Dewhirst RR. A simple diagnostic test for pupillary abnormality in diabetic autonomic neuropathy. Diabet Med. 1986; 3(1): 38–41.
- Smith SA, Smith SE. Evidence for a neuropathic aetiology in the small pupil of diabetes mellitus. Br J Ophthalmol. 1983; 67(2): 89–93.
- Karavanaki K, Davies AG, Hunt LP, Morgan MH, Baum JD. Pupil size in diabetes. Arch Dis Child. 1994; 71(6): 511–515.
- Hreidarsson AB. Pupil size in insulin-dependent diabetes. Relationship to duration, metabolic control, and long-term manifestations. Diabetes. 1982; 31(5 Pt 1): 442–448.
- Kiel M, Grabitz SD, Hopf S, Koeck T, Wild PS, Schmidtmann I, Lackner KJ, Münzel T, Beutel ME, Pfeiffer N, et al. Distribution of pupil size and associated factors: Results from the population-based gutenberg health study. J Ophthalmol. 2022; 2022: 9520512.
- Hreidarsson AB, Gundersen HJ. The pupillary response to light in type 1 (insulin-dependent) diabetes. Diabetologia. 1985; 28(11): 815–821.
- Kızıltoprak H, Tekin K, Sekeroglu MA, Yetkin E, Doguizi S, Yilmazbas P. Static and dynamic pupillary responses in patients with different stages of diabetic retinopathy. Neuro-Ophthalmology. 2019; 44(4): 226–235.
- Davis CQ, Waheed NK, Brigell M. Predicting progression to vision-threatening complications in diabetic retinopathy. Ophthalmol Sci. 2025; 5(6): 100859.
DOI: https://doi.org/10.2478/ahem-2026-0001 | Journal eISSN: 1732-2693
Language: English
Page range: 1 - 6
Submitted on: Nov 18, 2025
Accepted on: Jan 22, 2026
Published on: Feb 2, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2026 Sebastian Sirek, Aleksandra Górska, Krzysztof Marcinkowski, Dorota Pojda-Wilczek, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.